Navidea: Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024
Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced it will be hosting a virtual meeting of its stockholders at 1pm ET on Monday, July 8th, 2024.
Read full article »
CEO
- -Navidea is an Ohio-based biopharmaceutical company that researches and develops immunotherapeutics for the treatment of cancer, autoimmune, infectious, and inflammatory diseases.
Read more